PDCD1 and neoplasm: Notably, triple-positive PD-1+NKG2A+KIR+ NK cells represent approximately 13% of tumor-infiltrating PD-1+ NK cells overall, but this percentage rises to 19% in primary tumors and 23% in metastatic lesions (Fig. 8), highlighting their progressive enrichment at advanced disease sites.